23 reports

  • UNITED STATES - FORECAST FOR FOSPROPOFOL DISODIUM MARKET (MILLION US$), 2017 - 2022
  • MARKET (2011 - 2022)

It blocks the effects of excitatory neurotransmitter at the NMDA receptor, which results in depression of the central nervous system.

  • Anesthetics
  • North America
  • United States
  • Baxter International Inc.
  • PAION AG

Benzodiazepine Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018 - 2026 ##.

  • Anesthetics
  • Therapy
  • APAC
  • World
  • Forecast

This gas has many pharmaceutical purposes which include the treatment of brain diseases, lung problems, problem of stress, depression etc.

  • Anesthetics
  • Therapy
  • World
  • Demand
  • Forecast

ANXIETY AND DEPRESSION.

  • Anesthetics
  • Pharmaceutical
  • Sleep Aid
  • Demand
  • Roche Group

ALPRAZOLAM IS USED TO TREAT ANXIETY, PANIC DISORDERS, DEPRESSION, AND PREMENSTRUAL SYNDROME.

  • Anesthetics
  • OTC
  • Pharmaceutical
  • Sleep Aid
  • Demand
  • Adjuvant Drugs

ITS WIDESPREAD USE RESULTED FROM MANY DESIRABLE PROPERTIES, INCLUDING LOW SOLUBILITY, LIMITED CARDIOVASCULAR AND RESPIRATORY SYSTEM DEPRESSION, AND MINIMAL TOXICITY.

  • Anesthetics
  • China
  • Demand
  • Trade
  • Yichang Humanwell Pharmaceutical Co.

Our products are mostly used in the fields of the treatment of anesthesia sedation, analgesics, anti-psychosis, anti-anxiety/ depression, anti-epilepsy and other diseases.

  • Anesthetics
  • Pharmaceutical
  • China
  • Demand
  • AstraZeneca PLC
  • 3. Rocuronium

ITS WIDESPREAD USE RESULTED FROM MANY DESIRABLE PROPERTIES, INCLUDING LOW SOLUBILITY, LIMITED CARDIOVASCULAR AND RESPIRATORY SYSTEM DEPRESSION, AND MINIMAL TOXICITY.

  • Anesthetics
  • China
  • Demand
  • Trade
  • AstraZeneca PLC
  • Global xenon gas market in other industrial uses 2014-2019 (kiloliters)
  • Xenon gas in healthcare sector

You can easily book an appointment with one online.

  • Anesthetics
  • Air Liquide S.A.
  • Linde AG
  • Messer Group
  • Praxair, Inc.

Most patients only require one treatment for a full result.

  • Anesthetics
  • Clinical Trial
  • Drug Development
  • United States
  • Sinclair Pharma plc
  • NALOXONE - DRUG PROFILE
  • R&D Progress

Narcan is indicated for the complete or partial reversal of opioid depression, including respiratory depression, induced by natural and synthetic opioids.

  • Anesthetics
  • Opioid
  • United States
  • Product Initiative
  • Opiant Pharmaceuticals, Inc.
  • NALOXONE - DRUG PROFILE
  • R&D Progress

Narcan is indicated for the complete or partial reversal of opioid depression, including respiratory depression, induced by natural and synthetic opioids.

  • Anesthetics
  • Pharmaceutical
  • United States
  • Product Initiative
  • Opiant Pharmaceuticals, Inc.

NALSCUE® (NALOXONE HYDROCHLORIDE) NASAL SPRAY IS INDICATED FOR THE EMERGENCY TREATMENT OF CHARACTERIZED OR SUSPECTED OPIOID OVERDOSE IN ADULTS AND CHILDREN OLDER THAN ## MONTH, EVIDENCED BY RESPIRATORY DEPRESSION AND PENDING TREATMENT IN A MEDICAL DEPARTMENT.

  • Anesthetics
  • Clinical Trial
  • Nasal Drug Delivery
  • Pharmaceutical
  • Opiant Pharmaceuticals, Inc.
  • Clinical Trial profile. 14 Trial Title
  • Clinical Trial profile. 449 Trial Title

The prominent features of this report are - ##.

  • Anesthetics
  • Clinical Trial
  • Drug Development
  • Therapy
  • World
  • Official Title

The prominent features of this report are - ##.

  • Anesthetics
  • Clinical Trial
  • Drug Development
  • Pharmaceutical
  • World
  • ANESTHETIC EFFECT - PIPELINE BY MEDINCELL SA, H2 2018
  • lidocaine hydrochloride

One of the key targets of this trial was to assess the cardio stability during cardiac surgery with Remimazolam when compared to Propofol/ Sevoflurane, both of which are known to cause cardiac depression.

  • Anesthetics
  • Pharmaceutical
  • United States
  • Product Initiative
  • PAION AG
  • DZUVEO - DRUG PROFILE

Mood was assessed by the Beck Depression Inventory-II.

  • Anesthetics
  • United States
  • Company
  • Product Initiative
  • AcelRx Pharmaceuticals, Inc.
  • JAN 25, 2017: NARCAN (NALOXONE HCL) NASAL SPRAY 2MG APPROVED BY US FOOD AND DRUG ADMINISTRATION
  • 01/26/2017: OPIANT PHARMACEUTICALS ANNOUNCES FDA APPROVAL OF 2MG FORMULATION OF NARCAN (NALOXONE HCI) NASAL SPRAY

Narcan is indicated for the complete or partial reversal of opioid depression, including respiratory depression, induced by natural and synthetic opioids.

  • Anesthetics
  • Nasal Drug Delivery
  • Pharmaceutical
  • United States
  • Adapt Pharma Limited
  • Mar 07, 2018: Xenon Pharmaceuticals Reports 2017 Financial Results and Provides Corporate Update

At least three different genes have been implicated in HM, all of which can promote excessive glutamatergic (excitatory) neurotransmission leading to cortical spreading depression which mediates the progressive symptoms characteristic of HM.

  • Anesthetics
  • Pharmaceutical
  • Canada
  • Company
  • Xenon Pharmaceuticals Inc.
  • 5.2 ICU Sedation Drugs Market Players Product Comparison
  • 2.2.2 INTRAVENOUS ROUTE

Its effectiveness is one-fifth of isoflurane.

  • Anesthetics
  • Company
  • Company Financials
  • Demand
  • Orion Corporation

One of the key targets of this trial was to assess the cardiostability during cardiac surgery with Remimazolam when compared to Propofol/ Sevoflurane, both of which are known to cause cardiac depression.

  • Anesthetics
  • Pharmaceutical
  • United States
  • Product Initiative
  • PAION AG
  • Jan 16, 2019: EXPAREL achieves statistically significant reductions in opioid consumption and pain scores in cesarean section patients

MedinCell offers products for various indications including schizophrenia, pain and inflammation, depression, anaesthesia, organ transplant, and others.

  • Anesthetics
  • Opioid
  • Pharmaceutical
  • United States
  • Product Initiative
  • 3.2.2 RESTAINTS

Q. ##.

  • Anesthetics
  • United States
  • Market Size
  • Trade
  • Hospira, Inc.